The management of heart failure remains challenging despite many therapeutic advances.
Rigorous clinical trial evidence supports administration of multiple therapies, but utilization …

Optimizing management of patients with heart failure remains quite challenging despite
many significant advances in drug and device therapy for this syndrome. Although a large …

BACKGROUND: Measurement of circulating natriuretic peptides has been shown to play an
important role in diagnosis and prognosis in patients with chronic heart failure. Whether …

Use of biomarkers to guide outpatient therapy of heart failu... : Current Opinion in Cardiology
Use of biomarkers to guide outpatient therapy of heart failure : Current Opinion in Cardiology …

The current standard treatment of chronic heart failure (HF) is based on clinical judgment,
with the goal of achieving the maximally tolerated therapeutic program. The complexity of …

This review article addresses the question of whether biomarker-guided therapy is ready for
clinical implementation in chronic heart failure. The most well-known biomarkers in heart …

As more patients are diagnosed with heart failure each year, heart failure management has
become a growing public health issue. The development of new therapies and effective …

Heart failure is a clinical syndrome that manifests from various cardiac and noncardiac
abnormalities. Accordingly, rapid and readily accessible methods for diagnosis and risk …

While natriuretic peptide (NP) testing has gained widespread acceptance for the diagnosis
and prognosis of heart failure (HF), as well as risk stratification across the spectrum of …

The care of patients with heart failure can be challenging, with few objective tools available
to assist in therapy decision-making. Natriuretic peptides are powerfully prognostic …